SN7
SHORT NOTE
5M
Describe the normal mechanism of haemostasis. Add a note on the interpretation of the coagulation screening tests.
Definition
Haemostasis is the physiological process that arrests bleeding from an injured vessel while keeping the blood fluid elsewhere.
The Sequence
- 1. Vasoconstriction — transient reflex arteriolar spasm, augmented by endothelin → 2.
- Primary haemostasis — platelets adhere to exposed collagen via von Willebrand factor and GpIb → Platelets are activated, change shape and release ADP and TXA2 → They aggregate through GpIIb/IIIa bridged by fibrinogen → the primary platelet plug → 3.
- Secondary haemostasis — tissue factor activates the coagulation cascade → thrombin → fibrin → 4.
- Stabilisation — polymerised fibrin and platelet aggregates form a permanent plug → 5.
- Counter-regulation — tissue plasminogen activator and thrombomodulin limit the plug to the site of injury
The Coagulation Cascade
| Pathway | Factors | Test | Triggered by |
|---|---|---|---|
| Intrinsic | XII, XI, IX, VIII | APTT | Contact with a negatively charged surface |
| Extrinsic | VII | PT / INR | Tissue factor — the physiologically important trigger |
| Common | X, V, II (prothrombin), I (fibrinogen), XIII | Both PT and aPTT | — |
- Vitamin K dependent factors — II, VII, IX and X, plus proteins C and S; mnemonic "1972"
- Factor VII has the shortest half-life, which is why the PT/INR rises first in warfarin therapy, liver disease and vitamin K deficiency
CLINICAL PEARL
- Platelet disorders and coagulation disorders bleed differently.
- Platelet problems give immediate, superficial, mucocutaneous bleeding — petechiae, epistaxis, menorrhagia.
- Coagulation problems give delayed, deep bleeding — haemarthrosis, muscle haematoma. The history alone usually indicates which system is at fault.
Interpreting the Screening Tests
| PT | APTT | Platelets | Suggests |
|---|---|---|---|
| Prolonged | Normal | Normal | Factor VII deficiency; early warfarin, early liver disease, vitamin K deficiency |
| Normal | Prolonged | Normal | Haemophilia A (VIII) or B (IX); von Willebrand disease; heparin; antiphospholipid antibody |
| Prolonged | Prolonged | Normal | Common pathway defect; established liver disease; vitamin K deficiency |
| Prolonged | Prolonged | Low | DIC; massive transfusion |
| Normal | Normal | Low | Thrombocytopenia — ITP, hypersplenism, marrow failure |
| Normal | Normal | Normal | Vascular disorder, or a platelet function defect — test bleeding time |
Applied Aspects
- Aspirin inhibits cyclo-oxygenase irreversibly, and since platelets have no nucleus its effect lasts their whole 7–10 day lifespan — hence stopping it a week before surgery
- Clopidogrel blocks the ADP receptor; abciximab blocks GpIIb/IIIa — each targets a specific step above
- Warfarin acts on vitamin K dependent factors and is monitored by INR; heparin acts through antithrombin III and is monitored by aPTT
- Haemophilia A is X-linked, presenting with haemarthrosis and deep haematomas; von Willebrand disease is autosomal and mucocutaneous, and is the commonest inherited bleeding disorder
- Vitamin K deficiency of the newborn is prevented by a single intramuscular dose at birth — one of the most cost-effective interventions in medicine
All questions in Haemodynamic Disorders
- Q1Define oedema. Describe its pathogenesis with the mechanisms involved. Differentiate transudate from exudate. ★
- Q2Define thrombosis. Describe Virchow triad and the morphology and fate of a thrombus. ★
- Q3Define embolism. Classify emboli and describe pulmonary, fat, air and amniotic fluid embolism. ★
- Q4Define shock. Classify it and describe its pathogenesis, stages and morphology. ★
- Q5Define disseminated intravascular coagulation. Describe its causes, pathogenesis, clinical features and laboratory findings. ★
- SN1Define infarction. Classify infarcts and describe the factors determining their effects. ★
- SN2Differentiate hyperaemia from congestion. Describe chronic venous congestion of the lung, liver and spleen. ★
- SN3Classify haemorrhage and describe its effects. ★
- SN4Describe fat embolism syndrome with its pathogenesis and clinical features. ★
- SN5Describe Virchow triad and its significance in thrombosis. ★
- SN6Describe pulmonary thromboembolism with its sources, consequences and diagnosis. ★
- SN7Describe the normal mechanism of haemostasis. Add a note on the interpretation of the coagulation screening tests.